INSTI® HCV (Hepatitis C Virus) Antibody Self-Test Contrived Result Interpretation
NCT06357819 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 405
Last updated 2024-04-10
Summary
The purpose of this Interpretation Assessment was to document if "lay" people, non-professional and inexperienced in self-testing, were able to successfully perform the steps to use a Hepatitis C Virus (HCV) Self-Test (HCVST) device, without product familiarization \[demonstration\].
Conditions
- Hepatitis C
Interventions
- DEVICE
-
INSTI HCV Self Test
Each participant was provided with contrived INSTI membrane units by the study observer, in random order, and was asked to interpret the results using the INSTI HCV ST Instructions for Use.
Sponsors & Collaborators
-
bioLytical Laboratories
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-10-12
- Primary Completion
- 2023-12-17
- Completion
- 2023-12-17
Countries
- Canada
Study Locations
More Related Trials
-
Xpert Hepatitis-C Virus (HCV) Test on the GeneXpert Xpress System
NCT06508996 ·Status: COMPLETED
-
Rapid Point-of-care Testing for Hepatitis C in Community Clinics (RAPID-EC) Pilot Study
NCT03231930 ·Status: COMPLETED ·Phase: NA
-
Lay User Evaluation of the Panbio™ HCV Self-Test
NCT06605573 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The National Australian HCV Point-of-Care Testing Program - HCV Antibody Testing Minimal Dataset
NCT05713136 ·Status: RECRUITING
-
Treatment of Recently Acquired Hepatitis C Virus Infection
NCT01336010 ·Status: COMPLETED ·Phase: PHASE4
-
Hepatitis C Lab Testing Comparison Study
NCT06380166 ·Status: TERMINATED
-
PoC-HCV Genedrive Viral Detection Assay Validation Study
NCT02992184 ·Status: COMPLETED
-
HCV Test and Treat Utilizing Simplified HCV Patient Education
NCT05582681 ·Status: TERMINATED ·Phase: PHASE4
-
Hepatitis C: Community Testing and Treatment (CT2 Study Myanmar)
NCT03939013 ·Status: COMPLETED ·Phase: NA
-
Clinical Performance of Abbott RealTime Hepatitis C Virus (HCV) Genotype II Test
NCT00979979 ·Status: COMPLETED
-
Truenat™ HCV RNA Assay Evaluation
NCT04236973 ·Status: COMPLETED ·Phase: NA
-
Immune Response to Hepatitis C Virus
NCT00165919 ·Status: WITHDRAWN
-
Treatment of Chronic Hepatitis C With Pegylated Interferon and Ribavirin in Participants With/Without Substitution Therapy (P05255)
NCT00725751 ·Status: COMPLETED
-
Pharmacogenomics of Interferon and Ribavirin Treatment in Patients With Chronic Hepatitis C Virus Infection
NCT00164073 ·Status: UNKNOWN
-
High-dose IFN and PEG IFN for Induction Therapy in Difficult to Treat Genotype 1 Patients With Chronic HCV
NCT00381953 ·Status: COMPLETED ·Phase: PHASE3
-
NIDDM and IR in Combination Therapy for CHC
NCT00687999 ·Status: COMPLETED ·Phase: NA
-
High-Dose Ribavirin and Peginterferon to Treat Chronic Hepatitis C Genotype 1
NCT00735969 ·Status: COMPLETED ·Phase: PHASE2
-
Chronic Hepatitis C (CHC) - Genotype 3 Infection in Canada
NCT01100749 ·Status: TERMINATED
-
Access Anti-HCV Assay European Union (EU) Clinical Trial Protocol
NCT04971330 ·Status: COMPLETED
-
Study of Hepatitis C Virus (HCV) Viral Kinetics in HIV/HCV and HCV Patients
NCT00703560 ·Status: COMPLETED
-
Immune Response to Hepatitis C Virus
NCT00006301 ·Status: COMPLETED
-
A Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 Infection
NCT00217139 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Antiviral Activity and PK of MRD of BI 201335 in Chronic Hepatitis C Patients Both Treatment Naive and -Experienced
NCT00793793 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Immune Response to Hepatitis C Virus
NCT00237432 ·Status: COMPLETED
-
Study of Patients With Chronic Hepatitis C Infected With HCV LVL G1 and Effect of Peg-Intron Plus Rebetol Treatment (Study P04793)
NCT00709228 ·Status: COMPLETED